{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:59:30Z","timestamp":1790427570070,"version":"4.1.0"},"reference-count":39,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"vor","delay-in-days":268,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Case Reports in Otolaryngology"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>\n                    Mammary analog secretory carcinoma (MASC) is a rare malignant tumor of the salivary glands that exhibits significant morphological, immunohistochemical, and molecular similarities with secretory carcinoma of the breast, including the characteristic\n                    <jats:italic>ETV6<\/jats:italic>\n                    \u2013\n                    <jats:italic>NTRK3<\/jats:italic>\n                    gene fusion. The diagnosis of this condition remains challenging due to its histopathologic overlap with other low\u2010grade salivary gland tumors, such as acinic cell carcinoma and mucoepidermoid carcinoma. The following report details two cases of MASC manifesting in the right parotid gland of a 37\u2010year\u2010old male and a 23\u2010year\u2010old female. Both subjects exhibited slow\u2010growing, painless swellings and radiologic findings indicative of benign lesions. The surgical excision procedure was performed on the first patient via extracapsular dissection, while the second patient underwent superficial parotidectomy. Both procedures were carried out under the supervision of intraoperative facial nerve monitoring. A subsequent histopathological and immunohistochemical examination revealed a glandulocystic growth pattern with eosinophilic secretions and strong immunoreactivity for CK7, S100, and mammaglobin. Although molecular testing for the\n                    <jats:italic>ETV6<\/jats:italic>\n                    \u2013\n                    <jats:italic>NTRK3<\/jats:italic>\n                    fusion was not performed, the clinical, morphological, and immunophenotypic findings supported the diagnosis of low\u2010grade secretory carcinoma. The patients exhibited uncomplicated recovery, with transient facial nerve paresis in the second patient resolving within 3\u2009months. The first patient remains disease\u2010free after 40\u2009months of clinical and radiological follow\u2010up, while the second patient has shown no evidence of recurrence after 21\u2009months of follow\u2010up. The cases under consideration serve to emphasize the importance of integrating morphology and immunohistochemistry in routine practice, with molecular confirmation remaining the diagnostic gold standard whenever it is available. It is imperative to be aware of this entity to ensure an accurate diagnosis, optimal surgical management, and appropriate long\u2010term surveillance. Emerging evidence suggests that targeted therapy with NTRK inhibitors may represent a promising option for advanced or recurrent disease.\n                  <\/jats:p>","DOI":"10.1155\/crot\/5512895","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:22:36Z","timestamp":1790425356000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic and Therapeutic Perspectives on Parotid Mammary Analog Secretory Carcinoma: Two Case Reports and Literature Review"],"prefix":"10.1155","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2522-7768","authenticated-orcid":false,"given":"Francesco","family":"Ferragina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3182-5075","authenticated-orcid":false,"given":"Ida","family":"Barca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1979-2599","authenticated-orcid":false,"given":"Giuseppe","family":"Tarallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6002-7553","authenticated-orcid":false,"given":"Angelo R.","family":"Sottile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7655-1685","authenticated-orcid":false,"given":"Maria Grazia","family":"Ioppolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6365-8518","authenticated-orcid":false,"given":"Maria Giulia","family":"Cristofaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,26]]},"reference":[{"key":"e_1_2_13_1_2","doi-asserted-by":"crossref","unstructured":"Sk\u00e1lov\u00e1A. VanecekT. SimaR.et al. Mammary Analogue Secretory Carcinoma of Salivary Glands Containing the ETV6-NTRK3 Fusion Gene: A Hitherto Undescribed Salivary Gland Tumor Entity.","DOI":"10.1097\/PAS.0000000000000537"},{"key":"e_1_2_13_2_2","unstructured":"DamjanovI. S. F.andVranicS. Mammary Analogue Secretory Carcinoma (MASC) of the Salivary Gland: A New Tumor Entity."},{"key":"e_1_2_13_3_2","unstructured":"ItoY. IshibashiK. MasakiA.et al. Mammary Analogue Secretory Carcinoma of Salivary Glands: A Clinicopathologic and Molecular Study Including 2 Cases Harboring ETV6-X Fusion."},{"key":"e_1_2_13_4_2","unstructured":"GuzzoM. LocatiL. D. ProttF. J. GattaG. McGurkM. andLicitraL. Major and Minor Salivary Gland Tumors."},{"key":"e_1_2_13_5_2","unstructured":"LukP. P. SelingerC. I. EvistonT. J.et al. Mammary Analogue Secretory Carcinoma: An Evaluation of Its Clinicopathological and Genetic Characteristics."},{"key":"e_1_2_13_6_2","unstructured":"MajewskaH. Sk\u00e1lov\u00e1A. StodulskiD.et al. Mammary Analogue Secretory Carcinoma of Salivary Glands: A New Entity Associated with ETV6 Gene Rearrangement."},{"key":"e_1_2_13_7_2","unstructured":"GudmundssonJ. K. A. A.andAbtahiJ. The Accuracy of fine-needle Aspiration Cytology for Diagnosis of Parotid Gland Masses: A Clinicopathological Study of 114 Patients."},{"key":"e_1_2_13_8_2","unstructured":"HanF. LiuF. WangH.et al. Clinicopathologic Characterization of Secretory Carcinoma of Salivary Gland."},{"key":"e_1_2_13_9_2","unstructured":"BassaniS. FioriniD. DestefanisM. S.et al. Clinical Behavior and Molecular Insights of Secretory Carcinoma of Salivary Glands a Single Center Experience."},{"key":"e_1_2_13_10_2","unstructured":"WolkR. A. C. N. Update of newly-recognized Salivary Gland Neoplasms: Molecular and Immunohistochemical Findings and Clinical Importance."},{"key":"e_1_2_13_11_2","unstructured":"Sk\u00e1lov\u00e1A. VanecekT. SimpsonR. H.et al. Mammary Analogue Secretory Carcinoma of Salivary Glands: Molecular Analysis of 25 ETV6 Gene Rearranged Tumors with Lack of Detection of Classical ETV6-NTRK3 Fusion Transcript by Standard RT-PCR: Report of 4 Cases Harboring ETV6-X Gene Fusion."},{"key":"e_1_2_13_12_2","unstructured":"AvondetL. AdanR. BerensteinB. M.et al. Mammary Analogue Secretory Carcinoma of the Salivary Glands."},{"key":"e_1_2_13_13_2","unstructured":"LinxweilerM. WemmertS. BraunF. L.et al. Targeted Therapy in Salivary Gland Cancer: Prevalence of a Selected Panel of Actionable Molecular Alterations in a German Tertiary Referral Center Patient Cohort."},{"key":"e_1_2_13_14_2","unstructured":"ChioseaS. I. GriffithC. AssaadA. andSeethalaR. R. Clinicopathological Characterization of Mammary Analogue Secretory Carcinoma of Salivary Glands."},{"key":"e_1_2_13_15_2","unstructured":"BishopJ. A. YonescuR. BatistaD. EiseleD. W. andWestraW. H. Most Nonparotid \u201cAcinic Cell Carcinomas\u201d Represent Mammary Analog Secretory Carcinomas."},{"key":"e_1_2_13_16_2","unstructured":"StevensT. M. KovalovskyA. O. VelosaC.et al. Mammary Analog Secretory Carcinoma low-grade Salivary Duct Carcinoma and Mimickers: A Comparative Study."},{"key":"e_1_2_13_17_2","unstructured":"ChioseaS. I. GriffithC. AssaadA. andSeethalaR. R. The Profile of Acinic Cell Carcinoma After Recognition of Mammary Analog Secretory Carcinoma."},{"key":"e_1_2_13_18_2","unstructured":"KhaleleB. A. Systematic Review of Mammary Analog Secretory Carcinoma of Salivary Glands at 7 Years After Description."},{"key":"e_1_2_13_19_2","unstructured":"BishopJ. A. YonescuR. BatistaD. BegumS. EiseleD. W. andWestraW. H. Utility of Mammaglobin Immunohistochemistry as a Proxy Marker for the ETV6-NTRK3 Translocation in the Diagnosis of Salivary Mammary Analogue Secretory Carcinoma."},{"key":"e_1_2_13_20_2","unstructured":"ShahA. A. WenigB. M. LeGalloR. D. MillsS. E. andStelowE. B. Morphology in Conjunction with Immunohistochemistry is Sufficient for the Diagnosis of Mammary Analogue Secretory Carcinoma."},{"key":"e_1_2_13_21_2","unstructured":"ConnorA. Perez-Ordo\u00f1ezB. ShagoM. Sk\u00e1lov\u00e1A. andWeinrebI. Mammary Analog Secretory Carcinoma of Salivary Gland Origin with the ETV6 Gene Rearrangement by FISH: Expanded Morphologic and Immunohistochemical Spectrum of a Recently Described Entity."},{"key":"e_1_2_13_22_2","unstructured":"FehrA. L. T.andStenmanG. Mammary Analogue Secretory Carcinoma of the Salivary Glands with ETV6-NTRK3 Gene Fusion."},{"key":"e_1_2_13_23_2","unstructured":"Sk\u00e1lov\u00e1A. VanecekT. MajewskaH.et al. Mammary Analogue Secretory Carcinoma of Salivary Glands with high-grade Transformation: Report of 3 Cases with the ETV6-NTRK3 Gene Fusion and Analysis of TP53 \u03b2-catenin EGFR and CCND1 genes."},{"key":"e_1_2_13_24_2","unstructured":"KratochvilF. J. StewartJ. C. andMooreS. R. Mammary Analog Secretory Carcinoma of Salivary Glands: A Report of 2 Cases in the Lips."},{"key":"e_1_2_13_25_2","unstructured":"Rodr\u00edguez CoboJ. Lazu\u00e9n Fern\u00e1ndezS. Mayorga Fern\u00e1ndezM. M.et al. ETV6-NTRK3-positive Parotid Mammary Analogue Secretory Carcinoma: A Case Report."},{"key":"e_1_2_13_26_2","unstructured":"UranoM. NagaoT. MiyabeS. IshibashiK. HiguchiK. andKurodaM. Characterization of Mammary Analogue Secretory Carcinoma of the Salivary Gland: Discrimination from Its Mimics by the Presence of the ETV6-NTRK3 Translocation and Novel Surrogate Markers."},{"key":"e_1_2_13_27_2","unstructured":"BoonE. ValstarM. H. van der GraafW. T. A.et al. Clinicopathological Characteristics and Outcome of 31 Patients with ETV6-NTRK3 Fusion Gene Confirmed (Mammary Analogue) Secretory Carcinoma of Salivary Glands."},{"key":"e_1_2_13_28_2","unstructured":"PintoA. Nos\u00e9V. RojasC. FanY. S. andGomez-FernandezC. Searching for Mammary Analogue [Corrected] Secretory Carcinoma of Salivary Gland Among Its Mimics."},{"key":"e_1_2_13_29_2","unstructured":"JacksonB. S. PrattT. L. andVan RooyenA. Mammary Analogue Secretory Carcinoma: A Rare Salivary Gland Tumour."},{"key":"e_1_2_13_30_2","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14182017"},{"key":"e_1_2_13_31_2","unstructured":"AliyevaA. AgayarovO. Y. Y\u0131ld\u0131r\u0131mG. A. andMuderrisT. Surgical Histopathological and Clinical Outcomes of Parotid Gland Neoplasms: A 10-year Tertiary single-center Experience."},{"key":"e_1_2_13_32_2","unstructured":"DrilonA. LiG. DoganS.et al. What Hides Behind the MASC: Clinical Response and Acquired Resistance to Entrectinib After ETV6-NTRK3 Identification in a Mammary Analogue Secretory Carcinoma (MASC)."},{"key":"e_1_2_13_33_2","unstructured":"DemetriG. D. De BraudF. DrilonA.et al. Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients with NTRK Fusion-Positive Solid Tumors."},{"key":"e_1_2_13_34_2","unstructured":"DinN. U. F. S.andKayaniN. Mammary Analogue Secretory Carcinoma of Salivary Glands: A Clinicopathologic Study of 11 Cases."},{"key":"e_1_2_13_35_2","unstructured":"JiangQ. LiM. LiH. andChenL. Entrectinib a New multi-target Inhibitor for Cancer Therapy."},{"key":"e_1_2_13_36_2","unstructured":"DrilonA. SienaS. OuS. I.et al. Safety and Antitumor Activity of the Multitargeted Pan-TRK ROS1 and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)."},{"key":"e_1_2_13_37_2","unstructured":"StraubA. LinzC. StrobelS.et al. Mammary Analogue Secretory Carcinoma of a Salivary Gland of the Hard Palate with Contralateral Cervical Lymph Node Metastases: A Case Report."},{"key":"e_1_2_13_38_2","unstructured":"LuoW. LindleyS. W. LindleyP. H. KremplG. A. SeethalaR. R. andFungK. M. Mammary Analog Secretory Carcinoma of Salivary Gland with high-grade Histology Arising in Hard Palate Report of a Case and Review of Literature."},{"key":"e_1_2_13_39_2","unstructured":"AliyevaA. KarimovZ. andMuderrisT. Metastatic Salivary Gland Mammary Analogue Secretory Carcinoma (MASC) of Parotid Gland\u2013A Rare Case Report in the Literature Review."}],"container-title":["Case Reports in Otolaryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/crot\/5512895","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1155\/crot\/5512895","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/crot\/5512895","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:22:45Z","timestamp":1790425365000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/crot\/5512895"}},"subtitle":[],"editor":[{"given":"Parth","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1155\/crot\/5512895"],"URL":"https:\/\/doi.org\/10.1155\/crot\/5512895","archive":["Portico"],"relation":{},"ISSN":["2090-6765","2090-6773"],"issn-type":[{"value":"2090-6765","type":"print"},{"value":"2090-6773","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-12-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"5512895"}}